Ventilator-associated pneumonia (VAP) due to multidrug-resistant bacteria (MDR) is an
emerging problem worldwide. Both gram-negative and gram-positive microorganisms are …

Background: Nosocomial pneumonia (NP), hospital-acquired pneumonia (HAP) and
ventilator-associated pneumonia (VAP), is an important cause of morbidity and mortality in …

Objective. To describe the epidemiology of ventilator-associated pneumonia (VAP) in
community hospitals. Design and Setting. Prospective study in 31 community hospitals from …

Background & objectives: Among hospital-acquired infections, pneumonia is considered to
be the leading cause of death mainly in patients with mechanical ventilation in intensive …

Risk factors for the development of ventilator-associated pneumonia (VAP), as identified in
epidemiological studies, have provided a basis for testable interventions in randomized …

Ventilator-associate pneumonia (VAP) is the most common nosocomial infection in patients
in intensive care units (ICU). Because of its association with unwanted clinical outcomes …

Study objectives To prospectively identify the occurrence of ventilator-associated
pneumonia (VAP) in a community hospital, and to determine the risk factors for VAP and the …

Multidrug-resistant (MDR) organisms in ventilator-associated pneumonia were found in 49
of 107 patients and were associated with home antibiotics, pre-ventilator-associated …

Background Ventilator-associated pneumonia is the leading nosocomial infection in critically
ill patients. The frequency of ventilator-associated pneumonia caused by multidrug-resistant …

Abstract Purpose of Review Hospital-acquired and ventilator-associated pneumonia (VAP)
are frequent causes of infection among critically ill patients. VAP is the most common …